MICS does not harm the cornea

Article

Microincision cataract surgery (MICS) does not degrade the optical quality of the cornea or induce a modification in corneal astigmatism.

Microincision cataract surgery (MICS) does not degrade the optical quality of the cornea or induce a modification in corneal astigmatism, according to a report published in the January issue of the Journal of Cataract and Refractive Surgery.

Jorge Alio and colleagues from VISSUM, Instituto Oftalmologico de Alicante, Spain conducted a study to examine the effect of MICS on the optical quality of the cornea, characterized in terms of Seidel aberrations. A total of 25 eyes from 25 patients, with nuclear or corticonuclear cataract of grade 2+ to 4+, were enrolled.

MICS was performed using low ultrasound power through a 1.6 to 1.8 mm clear corneal incision placed on the axis of the positive corneal meridian. All eyes received an Acri.Smart 48S (Acri.Tec) intraocular lens (IOL). Seidel aberration root-mean-square (RMS) values were obtained with a 6 mm aperture using the CSO topographer (Costruzione Strumenti Oftalmici) preoperatively and one and three months postoperatively.

The total RMS following MICS decreased from a preoperative mean of 2.15±2.51 µm to 1.96±2.01 µm postoperatively; this decrease was not considered to be statistically significant. Furthermore, the difference between the preoperative corneal astigmatism (-0.80±0.76 D) and postoperative astigmatism (-0.63±0.62 D) was also not considered to be statistically significant, nor were the differences in Seidel aberrations, coma or higher-order aberrations.

The results of this study suggest that MICS does not degrade the optical quality of the cornea or induce a modification in corneal astigmatism.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.